{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:47:44Z","timestamp":1787003264883,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00445582"],"award-info":[{"award-number":["RS-2024-00445582"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-00266536"],"award-info":[{"award-number":["RS-2023-00266536"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68870-x","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:26:37Z","timestamp":1769743597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-TLR2 immunotherapy modulates neuron-to-oligodendrocyte propagation of \u03b1-synuclein in mouse and human models"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4369-7405","authenticated-orcid":false,"given":"Eun-Jin","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4569-2584","authenticated-orcid":false,"given":"Sangwoo","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1926-2857","authenticated-orcid":false,"given":"Yeonwoo William","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Seung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7921-4572","authenticated-orcid":false,"given":"Jimin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jung","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Seul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4869-8885","authenticated-orcid":false,"given":"Sang Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8681-1597","authenticated-orcid":false,"given":"Sung-Hye","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-5335","authenticated-orcid":false,"given":"Seung-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"68870_CR1","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","volume":"20","author":"H McCann","year":"2014","unstructured":"McCann, H., Stevens, C. H., Cartwright, H. & Halliday, G. M. Alpha-synucleinopathy phenotypes. Park. Relat. Disord. 20, S62\u2013S67 (2014).","journal-title":"Park. Relat. Disord."},{"key":"68870_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneurol.2017.26","volume":"13","author":"F Krismer","year":"2017","unstructured":"Krismer, F. & Wenning, G. K. Multiple system atrophy: insights into a rare and debilitating movement disorder. Nat. Rev. Neurol. 13, 232\u2013243 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"68870_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 14, 176 (2023).","journal-title":"Cell Death Dis."},{"key":"68870_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/01.jnen.0000171652.40083.15","volume":"64","author":"CM Muller","year":"2005","unstructured":"Muller, C. M. et al. Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J. Neuropathol. Exp. Neurol. 64, 623\u2013628 (2005).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"68870_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrneurol.2013.275","volume":"10","author":"HJ Lee","year":"2014","unstructured":"Lee, H. J., Bae, E. J. & Lee, S. J. Extracellular alpha-synuclein\u2014a novel and crucial factor in Lewy body diseases. Nat. Rev. Neurol. 10, 92\u201398 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"68870_CR6","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.15252\/embj.201593411","volume":"35","author":"S Abounit","year":"2016","unstructured":"Abounit, S. et al. Tunneling nanotubes spread fibrillar alpha-synuclein by intercellular trafficking of lysosomes. EMBO J. 35, 2120\u20132138 (2016).","journal-title":"EMBO J."},{"key":"68870_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2022.114059","volume":"436","author":"WP Ruf","year":"2023","unstructured":"Ruf, W. P., Meirelles, J. L. & Danzer, K. M. Spreading of alpha-synuclein between different cell types. Behav. Brain Res. 436, 114059 (2023).","journal-title":"Behav. Brain Res."},{"key":"68870_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim, C. et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 4, 1562 (2013).","journal-title":"Nat. Commun."},{"key":"68870_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00401-016-1648-8","volume":"133","author":"N Dzamko","year":"2017","unstructured":"Dzamko, N. et al. Toll-like receptor 2 is increased in neurons in Parkinson\u2019s disease brain and may contribute to alpha-synuclein pathology. Acta Neuropathol. 133, 303\u2013319 (2017).","journal-title":"Acta Neuropathol."},{"key":"68870_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-018-0276-2","volume":"13","author":"C Kim","year":"2018","unstructured":"Kim, C. et al. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating alpha-synuclein transmission and neuroinflammation. Mol. Neurodegener. 13, 43 (2018).","journal-title":"Mol. Neurodegener."},{"key":"68870_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s40478-023-01687-7","volume":"11","author":"T Kon","year":"2023","unstructured":"Kon, T. et al. Neuronal SNCA transcription during Lewy body formation. Acta Neuropathol. Commun. 11, 185 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"68870_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2157-4","volume":"581","author":"X Han","year":"2020","unstructured":"Han, X. et al. Construction of a human cell landscape at single-cell level. Nature 581, 303\u2013309 (2020).","journal-title":"Nature"},{"key":"68870_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","volume":"5","author":"M Djelloul","year":"2015","unstructured":"Djelloul, M. et al. Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models. Stem Cell Rep. 5, 174\u2013184 (2015).","journal-title":"Stem Cell Rep."},{"key":"68870_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106551","volume":"198","author":"T Kon","year":"2024","unstructured":"Kon, T. et al. SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy. Neurobiol. Dis. 198, 106551 (2024).","journal-title":"Neurobiol. Dis."},{"key":"68870_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s43587-024-00583-6","volume":"4","author":"L Adams","year":"2024","unstructured":"Adams, L., Song, M. K., Yuen, S., Tanaka, Y. & Kim, Y. S. A single-nuclei paired multiomic analysis of the human midbrain reveals age- and Parkinson\u2019s disease-associated glial changes. Nat. Aging 4, 364\u2013378 (2024).","journal-title":"Nat. Aging"},{"key":"68870_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-024-01104-7","volume":"17","author":"T Ishimoto","year":"2024","unstructured":"Ishimoto, T. et al. A novel mouse model for investigating alpha-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy. Mol. Brain 17, 28 (2024).","journal-title":"Mol. Brain"},{"key":"68870_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.celrep.2015.09.044","volume":"13","author":"C Kim","year":"2015","unstructured":"Kim, C. et al. Antagonizing neuronal toll-like receptor 2 prevents synucleinopathy by activating autophagy. Cell Rep. 13, 771\u2013782 (2015).","journal-title":"Cell Rep."},{"key":"68870_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40478-020-00950-5","volume":"8","author":"IS Piras","year":"2020","unstructured":"Piras, I. S. et al. Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the Parkinsonian and cerebellar sub-types of the disease. Acta Neuropathol. Commun. 8, 76 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"68870_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40478-017-0504-y","volume":"6","author":"V Refolo","year":"2018","unstructured":"Refolo, V. et al. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies. Acta Neuropathol. Commun. 6, 2 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"68870_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura, N. et al. Inoculation of alpha-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol. Neurodegener. 13, 21 (2018).","journal-title":"Mol. Neurodegener."},{"key":"68870_CR21","doi-asserted-by":"crossref","unstructured":"Franzen, O., Gan, L. M. & Bjorkegren, J. L. M. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database 2019, baz046 (2019).","DOI":"10.1093\/database\/baz046"},{"key":"68870_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-023-00699-0","volume":"19","author":"A Martirosyan","year":"2024","unstructured":"Martirosyan, A. et al. Unravelling cell type-specific responses to Parkinson\u2019s disease at single cell resolution. Mol. Neurodegener. 19, 7 (2024).","journal-title":"Mol. Neurodegener."},{"key":"68870_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi8287","volume":"10","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson\u2019s disease. Sci. Adv. 10, eadi8287 (2024).","journal-title":"Sci. Adv."},{"key":"68870_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/17590914.2025.2486962","volume":"17","author":"RD Fields","year":"2025","unstructured":"Fields, R. D. & Dutta, D. J. G-ratio commentary-why you\u2019ve been doing it wrong. ASN Neuro 17, 2486962 (2025).","journal-title":"ASN Neuro"},{"key":"68870_CR25","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats, P. et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. USA 106, 13010\u201313015 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68870_CR26","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee, H. J. et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 285, 9262\u20139272 (2010).","journal-title":"J. Biol. Chem."},{"key":"68870_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/glia.22611","volume":"62","author":"JF Reyes","year":"2014","unstructured":"Reyes, J. F. et al. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62, 387\u2013398 (2014).","journal-title":"Glia"},{"key":"68870_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbi.2024.07.004","volume":"121","author":"H Yamaguchi","year":"2024","unstructured":"Yamaguchi, H. et al. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of alpha-synuclein oligomers and phosphorylated alpha-synuclein aggregates. Brain Behav. Immun. 121, 122\u2013141 (2024).","journal-title":"Brain Behav. Immun."},{"key":"68870_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.stemcr.2017.12.001","volume":"10","author":"S Kaji","year":"2018","unstructured":"Kaji, S. et al. Pathological endogenous alpha-synuclein accumulation in oligodendrocyte precursor cells potentially induces inclusions in multiple system atrophy. Stem Cell Rep. 10, 356\u2013365 (2018).","journal-title":"Stem Cell Rep."},{"key":"68870_CR30","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake, M. et al. Prion-like spreading of pathological alpha-synuclein in brain. Brain 136, 1128\u20131138 (2013).","journal-title":"Brain"},{"key":"68870_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","volume":"45","author":"I Yazawa","year":"2005","unstructured":"Yazawa, I. et al. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45, 847\u2013859 (2005).","journal-title":"Neuron"},{"key":"68870_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13311-022-01287-8","volume":"20","author":"N Stefanova","year":"2023","unstructured":"Stefanova, N. A mouse model of multiple system atrophy: bench to bedside. Neurotherapeutics 20, 117\u2013126 (2023).","journal-title":"Neurotherapeutics"},{"key":"68870_CR33","doi-asserted-by":"publisher","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","volume":"25","author":"CW Shults","year":"2005","unstructured":"Shults, C. W. et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J. Neurosci. 25, 10689\u201310699 (2005).","journal-title":"J. Neurosci."},{"key":"68870_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-008-0372-4","volume":"116","author":"K Markopoulou","year":"2008","unstructured":"Markopoulou, K. et al. Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson\u2019s disease. Variability in familial Parkinson\u2019s disease. Acta Neuropathol. 116, 25\u201335 (2008).","journal-title":"Acta Neuropathol."},{"key":"68870_CR35","doi-asserted-by":"publisher","first-page":"2180 e2181","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen, P. et al. Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol. Aging 35, 2180 e2181\u20132180 (2014).","journal-title":"Neurobiol. Aging"},{"key":"68870_CR36","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.12688\/f1000research.12193.1","volume":"6","author":"HT Whittaker","year":"2017","unstructured":"Whittaker, H. T., Qui, Y., Bettencourt, C. & Houlden, H. Multiple system atrophy: genetic risks and alpha-synuclein mutations. F1000Research 6, 2072 (2017).","journal-title":"F1000Research"},{"key":"68870_CR37","unstructured":"Mao, X. et al. Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science 353, aah3374 (2016)."},{"key":"68870_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/19336896.2017.1334748","volume":"11","author":"L Urrea","year":"2017","unstructured":"Urrea, L., Ferrer, I., Gavin, R. & Del Rio, J. A. The cellular prion protein (PrPC) as neuronal receptor for alpha-synuclein. Prion 11, 226\u2013233 (2017).","journal-title":"Prion"},{"key":"68870_CR39","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.15252\/embj.201591397","volume":"34","author":"AN Shrivastava","year":"2015","unstructured":"Shrivastava, A. N. et al. Alpha-synuclein assemblies sequester neuronal alpha3-Na+\/K+-ATPase and impair Na+ gradient. EMBO J. 34, 2408\u20132423 (2015).","journal-title":"EMBO J."},{"key":"68870_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.nbd.2015.08.025","volume":"83","author":"YR Choi","year":"2015","unstructured":"Choi, Y. R. et al. FcgammaRIIB mediates the inhibitory effect of aggregated alpha-synuclein on microglial phagocytosis. Neurobiol. Dis. 83, 90\u201399 (2015).","journal-title":"Neurobiol. Dis."},{"key":"68870_CR41","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4049\/jimmunol.2100035","volume":"207","author":"H Scheiblich","year":"2021","unstructured":"Scheiblich, H. et al. Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct alpha-synuclein assemblies. J. Immunol. 207, 2143\u20132154 (2021).","journal-title":"J. Immunol."},{"key":"68870_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25767-1","volume":"12","author":"D Dutta","year":"2021","unstructured":"Dutta, D. et al. Selective targeting of the TLR2\/MyD88\/NF-kappaB pathway reduces alpha-synuclein spreading in vitro and in vivo. Nat. Commun. 12, 5382 (2021).","journal-title":"Nat. Commun."},{"key":"68870_CR43","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10753-019-01152-5","volume":"43","author":"K Ma","year":"2020","unstructured":"Ma, K., Guo, J., Wang, G., Ni, Q. & Liu, X. Toll-like receptor 2-mediated autophagy promotes microglial cell death by modulating the microglial M1\/M2 phenotype. Inflammation 43, 701\u2013711 (2020).","journal-title":"Inflammation"},{"key":"68870_CR44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1096\/fj.12-214312","volume":"27","author":"DS Arroyo","year":"2013","unstructured":"Arroyo, D. S. et al. Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy. FASEB J. 27, 299\u2013312 (2013).","journal-title":"FASEB J."},{"key":"68870_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40035-024-00448-3","volume":"13","author":"F Weiss","year":"2024","unstructured":"Weiss, F. et al. Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson\u2019s model. Transl. Neurodegener. 13, 62 (2024).","journal-title":"Transl. Neurodegener."},{"key":"68870_CR46","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/brain\/awz189","volume":"142","author":"Y Miki","year":"2019","unstructured":"Miki, Y. et al. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain 142, 2813\u20132827 (2019).","journal-title":"Brain"},{"key":"68870_CR47","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/awab017","volume":"144","author":"Y Miki","year":"2021","unstructured":"Miki, Y. et al. Identification of multiple system atrophy mimicking Parkinson\u2019s disease or progressive supranuclear palsy. Brain 144, 1138\u20131151 (2021).","journal-title":"Brain"},{"key":"68870_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/PL00007400","volume":"99","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H. & Takahashi, H. NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson\u2019s disease brains. Acta Neuropathol. 99, 14\u201320 (2000).","journal-title":"Acta Neuropathol."},{"key":"68870_CR49","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1440-1789.2001.00390.x","volume":"21","author":"T Yokoyama","year":"2001","unstructured":"Yokoyama, T., Kusunoki, J. I., Hasegawa, K., Sakai, H. & Yagishita, S. Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: correlation of the density of NCI and the degree of involvement of the pontine nuclei. Neuropathology 21, 145\u2013154 (2001).","journal-title":"Neuropathology"},{"key":"68870_CR50","doi-asserted-by":"crossref","unstructured":"Ayers, J. I. et al. Different alpha-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy. Proc. Natl. Acad. Sci. USA 119, e2113489119 (2022).","DOI":"10.1073\/pnas.2113489119"},{"key":"68870_CR51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz, M. et al. Discriminating alpha-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578, 273\u2013277 (2020).","journal-title":"Nature"},{"key":"68870_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Strohaker","year":"2019","unstructured":"Strohaker, T. et al. Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts. Nat. Commun. 10, 5535 (2019).","journal-title":"Nat. Commun."},{"key":"68870_CR53","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","volume":"557","author":"C Peng","year":"2018","unstructured":"Peng, C. et al. Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557, 558\u2013563 (2018).","journal-title":"Nature"},{"key":"68870_CR54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4062\/biomolther.2020.081","volume":"29","author":"YS Yoon","year":"2021","unstructured":"Yoon, Y. S. et al. Alpha-synuclein inclusion formation in human oligodendrocytes. Biomol. Ther. 29, 83\u201389 (2021).","journal-title":"Biomol. Ther."},{"key":"68870_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.103327","volume":"5","author":"H Kim","year":"2024","unstructured":"Kim, H. et al. Protocol for the acquisition and maturation of oligodendrocytes from neonatal rodent brains. STAR Protoc. 5, 103327 (2024).","journal-title":"STAR Protoc."},{"key":"68870_CR56","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea, G. et al. ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091\u20131093 (2009).","journal-title":"Bioinformatics"},{"key":"68870_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 14, 128 (2013).","journal-title":"BMC Bioinform."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68870-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:02:27Z","timestamp":1772632947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68870-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68870"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68870-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.L. is a co-founder and CEO of Neuramedy Co., Ltd. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2175"}}